MCID: GST044
MIFTS: 56

Gastritis

Categories: Gastrointestinal diseases, Immune diseases, Infectious diseases

Aliases & Classifications for Gastritis

MalaCards integrated aliases for Gastritis:

Name: Gastritis 12 29 54 6 43 15 62 17 71
Acute Gastric Mucosal Erosion 12 71
Erosive Gastropathy 12 71
Erosive Gastritis 12 71
Idiopathic Erosive/hemorrhagic Gastritis 71
Gastritis Erosive 54

Classifications:



External Ids:

Disease Ontology 12 DOID:4029
MeSH 43 D005756
NCIt 49 C26780
SNOMED-CT 67 4556007
ICD10 32 K29.7
UMLS 71 C0017152 C0267112 C2243088 more

Summaries for Gastritis

PubMed Health : 62 About gastritis: The membranes lining the stomach wall protect it from acid and germs. If this protective lining is irritated or damaged, it can become inflamed. Long-lasting inflammations can further damage the stomach lining and lead to stomach (gastric) ulcers. Inflammation of the stomach lining is called gastritis. It is usually caused by certain bacteria or anti-inflammatory medication. There are two kinds of gastritis: acute and chronic. Acute gastritis is typically accompanied by very noticeable stomach and bowel problems that usually go away again on their own after a few days. Chronic gastritis, on the other hand, sometimes goes unnoticed. People may only realize they have it when complications like stomach ulcers arise.

MalaCards based summary : Gastritis, also known as acute gastric mucosal erosion, is related to autoimmune atrophic gastritis and gastritis, familial giant hypertrophic, and has symptoms including dyspepsia and gastric irritation. An important gene associated with Gastritis is GAST (Gastrin), and among its related pathways/superpathways are Innate Immune System and Toll-Like receptor Signaling Pathways. The drugs Sucralfate and Methylcobalamin have been mentioned in the context of this disorder. Affiliated tissues include testes, colon and t cells.

Disease Ontology : 12 A stomach disease that is an inflammation of the lining of the stomach.

Wikipedia : 74 Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a... more...

Related Diseases for Gastritis

Diseases in the Gastritis family:

Autoimmune Gastritis Viral Gastritis
Bacterial Gastritis

Diseases related to Gastritis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 760, show less)
# Related Disease Score Top Affiliating Genes
1 autoimmune atrophic gastritis 34.9 GAST CHGA
2 gastritis, familial giant hypertrophic 34.7 TFF2 MUC6 GAST
3 autoimmune gastritis 34.5 TFF2 IL1B GAST
4 atrophic gastritis 33.9 TFF2 S100A8 PTGS2 PGC PGA5 PGA4
5 helicobacter pylori infection 33.1 S100A8 MUC6 IL1B GAST CXCL8 CXCL1
6 gastroduodenitis 32.3 S100A8 GAST
7 gastrointestinal ulceration, recurrent, with dysfunctional platelets 32.2 S100A8 PTGS2 HRH2 GAST
8 bile reflux 32.0 S100A8 PTGS2 GAST
9 stomach disease 31.9 TLR4 TFF2 S100A8 PTGS2 PGC MUC6
10 esophagitis 31.7 PTGS2 IL1B HRH2 GAST CXCL8
11 peptic ulcer disease 31.7 S100A8 PTGS2 IL1RN IL1B HRH2 GHRL
12 gastric ulcer 31.7 TFF2 S100A8 PTGS2 IL1RN IL1B HRH2
13 crohn's disease 31.5 TLR4 S100A8 IL1B CXCL8
14 duodenal ulcer 31.5 TLR4 S100A8 IL1RN IL1B HRH2 GAST
15 microinvasive gastric cancer 31.5 TFF2 S100A8 MUC6 GAST
16 gastric adenocarcinoma 31.4 S100A8 PTGS2 NOS2 IL1RN IL1B GAST
17 celiac disease 1 31.4 TLR4 IL1B GHRL GAST CXCL8
18 zollinger-ellison syndrome 31.3 HRH2 GAST CHGA
19 peptic esophagitis 31.3 S100A8 PTGS2 IL1B HRH2 GAST CXCL8
20 peritonitis 31.2 TLR4 NOS2 IL1B CXCL8
21 colitis 31.2 TLR4 PTGS2 NOS2 IL1B DEFA5 CXCL8
22 ulcerative colitis 31.2 TLR4 IL1RN IL1B CXCL8
23 gastroenteritis 31.2 IL1RN IL1B HRH2 CXCL8
24 portal hypertension 31.1 TLR4 NOS2 CXCL8
25 diarrhea 31.1 TLR4 IL1B HRH2 GAST CXCL8 CXCL1
26 proteasome-associated autoinflammatory syndrome 1 31.1 TLR4 PTGS2 NOS2 IL1RN IL1B CXCL8
27 toxic shock syndrome 31.0 TLR4 NOS2 IL1RN IL1B CXCL8
28 barrett esophagus 31.0 TFF2 PTGS2 MUC6 GAST
29 hernia, hiatus 31.0 HRH2 GHRL GAST
30 cholecystitis 31.0 TLR4 S100A8 MUC6
31 stomatitis 31.0 TLR4 IL1RN IL1B CXCL8
32 crohn's colitis 31.0 NOS2 IL1B DEFA5 CXCL8
33 exanthem 31.0 IL1RN IL1B CXCL8
34 gastroesophageal reflux 31.0 S100A8 PTGS2 PGC IL1RN IL1B HRH2
35 gastric cancer 31.0 TLR4 TFF2 S100A8 PTGS2 PGA5 PGA4
36 carcinoid tumors, intestinal 30.9 GAST CHGA
37 neutropenia 30.9 TLR4 IL1RN IL1B CXCL8
38 acute pancreatitis 30.9 TLR4 IL1RN IL1B CXCL8
39 gastric neuroendocrine neoplasm 30.9 GAST CHGA
40 postgastrectomy syndrome 30.9 GHRL GAST
41 duodenal gastrinoma 30.9 HRH2 GAST CHGA
42 amebiasis 30.8 TLR4 IL1B CXCL8
43 dysentery 30.8 TLR4 IL1B CXCL8
44 pharyngitis 30.8 PTGS2 IL1RN IL1B CXCL8
45 periodontitis 30.8 TLR4 PTGS2 IL1RN IL1B DEFB1 CXCL8
46 irritable bowel syndrome 30.8 TLR4 IL1B GHRL CXCL8
47 candidiasis 30.7 TLR4 IL1B DEFB1 CXCL8
48 constipation 30.7 PTGS2 NOS2 GHRL GAST CHGA
49 bronchopneumonia 30.7 TLR4 IL1B CXCL8
50 pericarditis 30.7 IL1RN IL1B CXCL8
51 bacterial infectious disease 30.6 TLR4 IL1RN IL1B DEFB1 CXCL8
52 appendicitis 30.6 TLR4 S100A8 IL1B CXCL8
53 pyelonephritis 30.6 TLR4 IL1B CXCL8
54 intestinal disease 30.6 TLR4 IL1B GHRL CXCL8
55 leishmaniasis 30.6 TLR4 NOS2 IL1B CXCL8
56 aspergillosis 30.6 TLR4 IL1RN IL1B CXCL8
57 diabetes mellitus, type i 30.5 TLR4 NOS2 IL1RN IL1B CXCL8
58 osteoarthritis 30.5 PTGS2 IL1RN IL1B CXCL8
59 pouchitis 30.5 TLR4 IL1RN CXCL8
60 pyoderma 30.5 IL1RN IL1B CXCL8
61 gastric gastrinoma 30.4 GAST CHGA
62 perinatal necrotizing enterocolitis 30.4 TLR4 IL1B CXCL8
63 juvenile rheumatoid arthritis 30.4 S100A8 IL1RN IL1B CXCL8
64 cystitis 30.4 TLR4 PTGS2 NOS2 CXCL8 CXCL1
65 peptic ulcer perforation 30.4 S100A8 HRH2 GAST
66 rheumatoid arthritis 30.4 TLR4 PTGS2 NOS2 IL1RN IL1B CXCL8
67 brucellosis 30.4 TLR4 IL1RN CXCL8
68 hepatitis a 30.3 TLR4 IL1B CXCL8
69 familial mediterranean fever 30.3 TLR4 IL1RN IL1B CXCL8
70 lymphadenitis 30.3 TLR4 IL1B CXCL8
71 trypanosomiasis 30.3 TLR4 NOS2 IL1B CXCL8
72 chagas disease 30.3 TLR4 NOS2 IL1B CXCL8
73 respiratory failure 30.3 TLR4 IL1RN IL1B CXCL8
74 urethritis 30.3 TLR4 IL1B DEFA5 CXCL8
75 metal allergy 30.2 TLR4 IL1B
76 tonsillitis 30.2 TLR4 IL1B DEFB1 CXCL8 CXCL1
77 diabetes mellitus 30.2 TLR4 PTGS2 NOS2 IL1RN IL1B GHRL
78 toxoplasmosis 30.2 TLR4 NOS2 IL1B
79 pancreatic adenocarcinoma 30.2 PTGS2 MUC6 IL1B GAST CXCL8 CHGA
80 arthritis 30.1 TLR4 PTGS2 IL1RN IL1B CXCL8 CXCL1
81 pulmonary disease, chronic obstructive 30.1 TLR4 IL1B DEFB1 CXCL8
82 osteoporosis 29.9 TLR4 PTGS2 IL1RN IL1B GHRL CXCL8
83 inflammatory bowel disease 29.9 TLR4 TFF2 S100A8 PTGS2 NOS2 IL1RN
84 multiple sclerosis 29.9 TLR4 NOS2 IL1RN IL1B CXCL8 CXCL1
85 cystic fibrosis 29.9 TLR4 S100A8 MUC6 IL1B DEFB1 CXCL8
86 pneumonia 29.8 TLR4 IL1RN IL1B HRH2 CXCL8 CXCL1
87 non-alcoholic steatohepatitis 29.7 TLR4 GHRL CXCL8
88 collagenous gastritis 12.6
89 bacterial gastritis 12.5
90 alcoholic gastritis 12.5
91 herpetic gastritis 12.5
92 granulomatous gastritis 12.5
93 chronic erosive gastritis 12.4
94 lymphocytic gastritis 12.4
95 eosinophilic gastritis 12.4
96 necrotizing gastritis 12.3
97 cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and mental retardation 12.3
98 viral gastritis 12.3
99 pediatric collagenous gastritis 12.3
100 fungal gastritis 12.2
101 pernicious anemia 11.6
102 eosinophilic gastroenteritis 11.5
103 lubani-al saleh-teebi syndrome 11.4
104 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 11.2
105 immunodeficiency 12 11.2
106 duodenitis 11.1
107 chief cell adenoma 10.7 PGA5 PGA4 PGA3
108 systemic onset juvenile idiopathic arthritis 10.7 IL1RN IL1B
109 bagassosis 10.7 IL1B CXCL8
110 esophagus melanoma 10.7 S100A8 CXCL8
111 deficiency anemia 10.7
112 funisitis 10.7 S100A8 IL1B CXCL8
113 vulvar vestibulitis syndrome 10.7 IL1RN IL1B
114 leukoregulin 10.7 PTGS2 CXCL8
115 gastrointestinal neuroendocrine benign tumor 10.7 GAST CHGA
116 necrotizing fasciitis 10.7 IL1RN IL1B CXCL8
117 macular degeneration, age-related, 10 10.7 PGA4 PGA3
118 mixed ductal-endocrine carcinoma 10.7 GAST CHGA
119 non-functioning pancreatic endocrine tumor 10.7 GAST CHGA
120 adult-onset still's disease 10.7 IL1RN IL1B CXCL8
121 prosthetic joint infection 10.7 TLR4 IL1B
122 indolent myeloma 10.7 IL1RN IL1B
123 acute generalized exanthematous pustulosis 10.7 PTGS2 CXCL8
124 cecal disease 10.7 IL1B CXCL8 CHGA
125 aseptic meningitis 10.6 IL1RN IL1B CXCL8
126 cerebral artery occlusion 10.6 PTGS2 NOS2 IL1B
127 iron metabolism disease 10.6
128 dental pulp disease 10.6 TLR4 IL1B CXCL8
129 viral encephalitis 10.6 PTGS2 IL1B CXCL8
130 goblet cell carcinoid 10.6 GAST CHGA
131 cervicitis 10.6 TLR4 IL1B CXCL8
132 idiopathic neutropenia 10.6 TLR4 IL1RN IL1B
133 blood group, globoside system 10.6 TLR4 IL1B CXCL8
134 hypersensitivity reaction type iv disease 10.6 IL1RN IL1B CXCL8
135 endophthalmitis 10.6 IL1B DEFB1 CXCL8
136 pyelitis 10.6 TLR4 IL1B CXCL8
137 vaginitis 10.6 TLR4 IL1B CXCL8
138 streptococcus pneumonia 10.6 TLR4 IL1B CXCL8
139 apnea, obstructive sleep 10.6 IL1B GHRL CXCL8
140 fallopian tube disease 10.6 TLR4 IL1B CXCL8
141 gingival disease 10.6 TLR4 IL1B CXCL8
142 prostatitis 10.6 PTGS2 IL1B CXCL8
143 muckle-wells syndrome 10.6 IL1RN IL1B CXCL8
144 vaginal disease 10.6 TLR4 IL1B CXCL8
145 middle ear disease 10.6 TLR4 IL1B CXCL8
146 endocardium disease 10.6 TLR4 IL1B CXCL8
147 hidradenitis suppurativa 10.6 TLR4 S100A8 IL1B
148 hidradenitis 10.6 TLR4 S100A8 IL1B
149 coccidiosis 10.6 TLR4 IL1B CXCL8
150 septic arthritis 10.6 TLR4 IL1B CXCL8
151 anus disease 10.6 TLR4 IL1B CXCL8
152 blau syndrome 10.6 TLR4 IL1RN IL1B
153 rectal disease 10.6 TLR4 IL1B CXCL8
154 oral candidiasis 10.6 IL1RN DEFB1 CXCL8
155 preterm premature rupture of the membranes 10.6 TLR4 IL1B CXCL8
156 leukemia, acute monocytic 10.6 TLR4 IL1B CXCL8
157 opportunistic mycosis 10.6 TLR4 IL1B CXCL8
158 pneumoconiosis 10.6 PTGS2 IL1RN IL1B CXCL8
159 appendix lymphoma 10.6 GAST CHGA
160 nasal cavity disease 10.6 TLR4 IL1B CXCL8
161 pleurisy 10.6 TLR4 IL1RN CXCL8
162 fungal infectious disease 10.6 TLR4 IL1B CXCL8
163 common cold 10.6 TLR4 IL1B CXCL8
164 uveal disease 10.6 IL1RN IL1B CXCL8
165 autoimmune disease of gastrointestinal tract 10.6 TLR4 IL1B GAST
166 q fever 10.6 TLR4 IL1RN IL1B
167 nose disease 10.6 TLR4 IL1B CXCL8
168 respiratory allergy 10.6 TLR4 IL1B CXCL8
169 neuritis 10.6 PTGS2 IL1B CXCL8
170 commensal bacterial infectious disease 10.6 TLR4 IL1B CXCL8
171 chlamydia pneumonia 10.6 TLR4 S100A8 IL1B CXCL8
172 autoimmune disease 10.6
173 glucagonoma 10.6 GAST CHGA
174 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.6
175 sebaceous gland disease 10.6 TLR4 IL1RN IL1B CXCL8
176 periodic fever, familial, autosomal dominant 10.6 TLR4 IL1RN IL1B CXCL8
177 conjunctival disease 10.6 TLR4 IL1RN IL1B CXCL8
178 squamous blepharitis 10.6 S100A8 NOS2
179 endometrial disease 10.6 TLR4 PTGS2 IL1B CXCL8
180 aphthous stomatitis 10.6 TLR4 IL1RN IL1B CXCL8
181 silicosis 10.6 TLR4 IL1RN IL1B CXCL8
182 chlamydia 10.6 TLR4 NOS2 IL1B CXCL8
183 chorioamnionitis 10.6 TLR4 IL1RN IL1B CXCL8
184 pulpitis 10.6 TLR4 NOS2 IL1B CXCL8
185 osteomyelitis 10.6 TLR4 IL1RN IL1B CXCL8
186 gastric diffuse adenocarcinoma 10.6 S100A8 MUC6 GAST
187 contact dermatitis 10.6 TLR4 IL1B CXCL8
188 cutaneous leishmaniasis 10.6 TLR4 NOS2 IL1B CXCL8
189 pancreatic cholera 10.6 HRH2 GAST CHGA
190 pancreatic gastrinoma 10.6 HRH2 GAST CHGA
191 endocrine pancreas disease 10.6 HRH2 GAST CHGA
192 visceral leishmaniasis 10.6 TLR4 NOS2 IL1B CXCL8
193 lymphoma, mucosa-associated lymphoid type 10.6
194 duodenum disease 10.6 S100A8 MUC6 GAST
195 relapsing-remitting multiple sclerosis 10.6 TLR4 IL1RN IL1B CXCL8
196 gout 10.6 TLR4 PTGS2 IL1B CXCL8
197 shigellosis 10.6 TLR4 IL1B CXCL8
198 leprosy 3 10.6 TLR4 IL1B CXCL8
199 duodenogastric reflux 10.6
200 pulmonary edema 10.6 NOS2 IL1B CXCL8
201 vulvovaginal candidiasis 10.5 IL1RN DEFB1 DEFA5
202 otitis media 10.5 TLR4 IL1RN IL1B CXCL8
203 iron deficiency anemia 10.5
204 reactive arthritis 10.5 TLR4 IL1B CXCL8
205 alcoholic liver cirrhosis 10.5 TLR4 IL1B CXCL8
206 adenocarcinoma 10.5
207 mucositis 10.5 NOS2 IL1B GHRL
208 toxic encephalopathy 10.5 TLR4 PTGS2 IL1B
209 gastrointestinal neuroendocrine tumor 10.5 GAST CHGA
210 gastrointestinal system benign neoplasm 10.5 PTGS2 GAST CHGA
211 behcet syndrome 10.5 TLR4 IL1RN IL1B CXCL8
212 placenta disease 10.5 TLR4 IL1B CXCL8
213 bacterial sepsis 10.5 TLR4 NOS2 IL1RN IL1B CXCL8
214 brain edema 10.5 NOS2 IL1RN IL1B
215 bone inflammation disease 10.5 TLR4 PTGS2 IL1RN IL1B CXCL8
216 parasitic protozoa infectious disease 10.5 TLR4 IL1B CXCL8
217 bacteriuria 10.5 TLR4 CXCL8 CXCL1
218 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.5
219 cerebral palsy 10.5 TLR4 PTGS2 NOS2 IL1B CXCL8
220 meningococcemia 10.5 IL1RN IL1B
221 aggressive periodontitis 10.5 TLR4 IL1RN IL1B DEFB1 CXCL8
222 corneal disease 10.5 TLR4 IL1B CXCL8
223 yellow fever 10.5 IL1RN IL1B CXCL1
224 salmonellosis 10.5 TLR4 IL1B DEFB1 DEFA5
225 autoimmune disease of musculoskeletal system 10.5 TLR4 IL1B CXCL8
226 vitamin b12 deficiency 10.5
227 endometritis 10.5 TLR4 IL1B CXCL8 CXCL1
228 sleep apnea 10.5 IL1B GHRL CXCL8
229 acute cystitis 10.5 TLR4 IL1B CXCL8 CXCL1
230 chronic fatigue syndrome 10.5 TLR4 IL1B CXCL8
231 legionellosis 10.5 TLR4 IL1B CXCL8 CXCL1
232 bacterial meningitis 10.4 TLR4 IL1B CXCL8 CXCL1
233 meningitis 10.4 TLR4 IL1B CXCL8 CXCL1
234 bacterial pneumonia 10.4 TLR4 IL1B CXCL8 CXCL1
235 bacterial vaginosis 10.4 TLR4 IL1RN IL1B DEFA5 CXCL8
236 alcoholic hepatitis 10.4 TLR4 IL1B CXCL8 CXCL1
237 thyroiditis 10.4
238 adult respiratory distress syndrome 10.4 IL1B CXCL8 CXCL1
239 gastric lymphoma 10.4
240 bronchial disease 10.4 TLR4 IL1B CXCL8
241 lymphoma 10.4
242 keratitis, hereditary 10.4 TLR4 IL1B CXCL1
243 primary bacterial infectious disease 10.4 TLR4 IL1B CXCL8
244 collagenous colitis 10.4
245 gastrointestinal system disease 10.4
246 non-hypoproteinemic hypertrophic gastropathy 10.4
247 eye disease 10.4 TLR4 IL1RN IL1B DEFB1 CXCL8
248 liver cirrhosis 10.4
249 pulmonary fibrosis, idiopathic 10.4 TLR4 IL1RN IL1B CXCL8 CXCL1
250 adenoma 10.3
251 neisseria meningitidis infection 10.3 TLR4 IL1RN
252 cardiac rupture 10.3 S100A8 CXCL8
253 sarcoidosis 1 10.3
254 cytokine deficiency 10.3
255 nodal marginal zone lymphoma 10.3
256 hypereosinophilic syndrome 10.3
257 solid adenocarcinoma with mucin production 10.3 MUC6 CHGA
258 hashimoto thyroiditis 10.3
259 syphilis 10.3
260 endometrial small cell carcinoma 10.2 GAST CHGA
261 alcohol dependence 10.2
262 overgrowth syndrome 10.2
263 varicose veins 10.2
264 pyloric stenosis 10.2
265 chickenpox 10.2
266 hypertension, essential 10.2 TLR4 PTGS2 NOS2 IL1B GHRL CXCL8
267 esophageal cancer 10.2
268 alcohol use disorder 10.2
269 neuroendocrine tumor 10.2
270 b-cell lymphoma 10.2
271 posttransplant acute limbic encephalitis 10.2
272 gastroparesis 10.2
273 pancreatitis 10.2
274 gastrinoma 10.2
275 severe combined immunodeficiency 10.2
276 gastrointestinal stromal tumor 10.2
277 hypothyroidism 10.2
278 purpura 10.2
279 vasculitis 10.2
280 polyposis, gastric 10.1
281 vitiligo-associated multiple autoimmune disease susceptibility 6 10.1
282 pancreatic cancer 10.1
283 vitiligo-associated multiple autoimmune disease susceptibility 1 10.1
284 esophageal varix 10.1
285 allergic hypersensitivity disease 10.1
286 dumping syndrome 10.1
287 urticaria 10.1
288 dermatitis 10.1
289 argyria 10.1
290 lymphocytic colitis 10.1
291 ileitis 10.1
292 cholelithiasis 10.1
293 pulmonary tuberculosis 10.1
294 liver disease 10.1
295 hemolytic anemia 10.1
296 acquired immunodeficiency syndrome 10.1
297 mucormycosis 10.1
298 47,xyy 10.1
299 pfeiffer syndrome 10.1
300 immune deficiency disease 10.1
301 gallbladder disease 1 10.1
302 homocysteinemia 10.1
303 primary biliary cirrhosis 10.1
304 linitis plastica 10.1
305 secondary syphilis 10.1
306 dysphagia 10.1
307 myocardial infarction 10.0 TLR4 PTGS2 IL1RN IL1B GHRL CXCL8
308 dermatitis herpetiformis, familial 10.0
309 body mass index quantitative trait locus 1 10.0
310 marginal zone b-cell lymphoma 10.0
311 protein-losing enteropathy 10.0
312 cholera 10.0
313 macrocytic anemia 10.0
314 signet ring cell adenocarcinoma 10.0
315 plasmacytoma 10.0
316 kidney disease 10.0
317 active peptic ulcer disease 10.0
318 dermatitis herpetiformis 10.0
319 familial glucocorticoid deficiency 10.0
320 ige responsiveness, atopic 10.0
321 human immunodeficiency virus type 1 10.0
322 esophagitis, eosinophilic, 1 10.0
323 microscopic colitis 10.0
324 giardiasis 10.0
325 gastrojejunal ulcer 10.0
326 goiter 10.0
327 graves' disease 10.0
328 megaloblastic anemia 10.0
329 thrombocytopenia 10.0
330 autoimmune hepatitis 10.0
331 food allergy 10.0
332 multiple endocrine neoplasia 10.0
333 herpes simplex 10.0
334 amyloidosis 10.0
335 biliary tract disease 10.0
336 cytomegalovirus infection 10.0
337 asthma 10.0 TLR4 NOS2 IL1RN IL1B HRH2 GHRL
338 multiple endocrine neoplasia, type i 10.0
339 systemic lupus erythematosus 10.0
340 enterocolitis 10.0
341 metabolic acidosis 10.0
342 rickets 10.0
343 microcytic anemia 10.0
344 squamous cell carcinoma 10.0
345 vascular disease 10.0
346 neuroendocrine carcinoma 10.0
347 gastric antral vascular ectasia 10.0
348 gastric dilatation 10.0
349 tubular adenocarcinoma 10.0
350 lymphopenia 10.0
351 end stage renal disease 10.0
352 lupus erythematosus 10.0
353 cholangitis 10.0
354 48,xyyy 10.0
355 carcinoid syndrome 10.0
356 kaposi sarcoma 9.9
357 thrombophilia due to thrombin defect 9.9
358 anemia, autoimmune hemolytic 9.9
359 autism 9.9
360 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
361 myasthenia gravis 9.9
362 periodontitis, chronic 9.9
363 aging 9.9
364 anxiety 9.9
365 mycobacterium tuberculosis 1 9.9
366 aplastic anemia 9.9
367 graft-versus-host disease 9.9
368 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.9
369 peripheral vascular disease 9.9
370 diffuse large b-cell lymphoma 9.9
371 immunoglobulin alpha deficiency 9.9
372 thrombotic thrombocytopenic purpura 9.9
373 heart disease 9.9
374 common variable immunodeficiency 9.9
375 dementia 9.9
376 polyneuropathy 9.9
377 autoimmune polyendocrine syndrome 9.9
378 glossitis 9.9
379 calcinosis 9.9
380 hepatitis 9.9
381 orchitis 9.9
382 gingivitis 9.9
383 proctitis 9.9
384 neurotic disorder 9.9
385 thyroid gland disease 9.9
386 t-cell lymphoblastic leukemia/lymphoma 9.9
387 hyperthyroidism 9.9
388 myocarditis 9.9
389 alopecia 9.9
390 autoimmune oophoritis 9.9
391 leukemia, t-cell, chronic 9.9
392 mallory-weiss syndrome 9.9
393 polymyositis 9.9
394 splenomegaly 9.9
395 autonomic dysfunction 9.9
396 epstein-barr virus-associated gastric carcinoma 9.9
397 spondyloarthropathy 1 9.8
398 atherosclerosis susceptibility 9.8
399 atrial standstill 1 9.8
400 colorectal cancer 9.8
401 hepatocellular carcinoma 9.8
402 diabetes mellitus, noninsulin-dependent 9.8
403 hypercholesterolemia, familial, 1 9.8
404 intussusception 9.8
405 meckel diverticulum 9.8
406 neutrophil migration 9.8
407 greig cephalopolysyndactyly syndrome 9.8
408 thrombocytopenic purpura, autoimmune 9.8
409 lymphoma, hodgkin, classic 9.8
410 ocular motor apraxia 9.8
411 intrinsic factor deficiency 9.8
412 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 9.8
413 cyclic vomiting syndrome 9.8
414 ataxia and polyneuropathy, adult-onset 9.8
415 stroke, ischemic 9.8
416 leukemia, acute myeloid 9.8
417 dermatitis, atopic 9.8
418 anorexia nervosa 9.8
419 kala-azar 1 9.8
420 hepatitis c virus 9.8
421 diabetes mellitus, ketosis-prone 9.8
422 myelodysplastic syndrome 9.8
423 cholangiocarcinoma 9.8
424 melanoma, cutaneous malignant 10 9.8
425 familial adenomatous polyposis 9.8
426 adult t-cell leukemia 9.8
427 hypochromic microcytic anemia 9.8
428 congenital intrinsic factor deficiency 9.8
429 lymphoplasmacytic lymphoma 9.8
430 colorectal adenoma 9.8
431 follicular lymphoma 9.8
432 gallbladder disease 9.8
433 cardiac arrest 9.8
434 bone resorption disease 9.8
435 endocarditis 9.8
436 cardia cancer 9.8
437 sarcoma 9.8
438 primary hyperparathyroidism 9.8
439 disseminated intravascular coagulation 9.8
440 diphtheria 9.8
441 hemopericardium 9.8
442 autonomic neuropathy 9.8
443 pericardial effusion 9.8
444 inflammatory spondylopathy 9.8
445 pica disease 9.8
446 pancytopenia 9.8
447 hepatic coma 9.8
448 acute leukemia 9.8
449 guillain-barre syndrome 9.8
450 esophageal candidiasis 9.8
451 hyperparathyroidism 9.8
452 atrophic glossitis 9.8
453 keratosis 9.8
454 melanoma 9.8
455 acute kidney failure 9.8
456 histiocytosis 9.8
457 cellulitis 9.8
458 superior mesenteric artery syndrome 9.8
459 systemic scleroderma 9.8
460 spindle cell sarcoma 9.8
461 rhinitis 9.8
462 intrahepatic cholangiocarcinoma 9.8
463 peripheral nervous system disease 9.8
464 congestive heart failure 9.8
465 esophageal disease 9.8
466 connective tissue disease 9.8
467 spondylitis 9.8
468 herpes zoster 9.8
469 scarlet fever 9.8
470 myeloid leukemia 9.8
471 neuropathy 9.8
472 fatty liver disease 9.8
473 postcholecystectomy syndrome 9.8
474 hemorrhoid 9.8
475 polyarteritis nodosa 9.8
476 hypoglycemia 9.8
477 plummer vinson syndrome 9.8
478 ulcerative proctitis 9.8
479 hypotonia 9.8
480 inflammatory myopathy with abundant macrophages 9.8
481 primary eosinophilic gastrointestinal disease 9.8
482 eosinophilic colitis 9.8
483 cardiogenic shock 9.8
484 refractory anemia 9.8
485 polyendocrinopathy 9.8
486 streptococcal toxic-shock syndrome 9.8
487 neurofibromatosis, type ii 9.7
488 arteries, anomalies of 9.7
489 breast cancer 9.7
490 immunoglobulin a deficiency 1 9.7
491 hypertriglyceridemia, familial 9.7
492 leukemia, chronic lymphocytic 9.7
493 lipomatosis, multiple 9.7
494 marfan syndrome 9.7
495 migraine with or without aura 1 9.7
496 myositis 9.7
497 pemphigus vulgaris, familial 9.7
498 peutz-jeghers syndrome 9.7
499 polyposis, skin pigmentation, alopecia, and fingernail changes 9.7
500 pulmonary hypertension, primary, 1 9.7
501 pyloric stenosis, infantile hypertrophic, 1 9.7
502 dowling-degos disease 1 9.7
503 schistosoma mansoni infection, susceptibility/ 9.7
504 tobacco addiction 9.7
505 volvulus of midgut 9.7
506 anemia, hypochromic microcytic, with iron overload 1 9.7
507 iron-refractory iron deficiency anemia 9.7
508 bronchiectasis with or without elevated sweat chloride 1 9.7
509 chylomicron retention disease 9.7
510 myeloma, multiple 9.7
511 myxedema 9.7
512 sjogren syndrome 9.7
513 insulin-like growth factor i 9.7
514 graves disease 1 9.7
515 body mass index quantitative trait locus 11 9.7
516 hemophilia a 9.7
517 otopalatodigital syndrome, type i 9.7
518 retinitis pigmentosa 11 9.7
519 yemenite deaf-blind hypopigmentation syndrome 9.7
520 body mass index quantitative trait locus 9 9.7
521 xanthomatosis 9.7
522 body mass index quantitative trait locus 8 9.7
523 sickle cell anemia 9.7
524 panbronchiolitis, diffuse 9.7
525 langerhans cell histiocytosis 9.7
526 lymphoma, non-hodgkin, familial 9.7
527 celiac disease 5 9.7
528 patent ductus arteriosus 1 9.7
529 body mass index quantitative trait locus 4 9.7
530 psoriatic arthritis 9.7
531 body mass index quantitative trait locus 10 9.7
532 autoimmune disease 1 9.7
533 body mass index quantitative trait locus 7 9.7
534 severe cutaneous adverse reaction 9.7
535 granulomatosis with polyangiitis 9.7
536 chromosome 16p13.3 deletion syndrome, proximal 9.7
537 bone mineral density quantitative trait locus 8 9.7
538 inflammatory bowel disease 19 9.7
539 microtia, hearing impairment, and cleft palate 9.7
540 body mass index quantitative trait locus 12 9.7
541 body mass index quantitative trait locus 14 9.7
542 microvascular complications of diabetes 3 9.7
543 microvascular complications of diabetes 4 9.7
544 microvascular complications of diabetes 6 9.7
545 microvascular complications of diabetes 7 9.7
546 bronchiectasis with or without elevated sweat chloride 2 9.7
547 bronchiectasis with or without elevated sweat chloride 3 9.7
548 bone mineral density quantitative trait locus 15 9.7
549 cholangitis, primary sclerosing 9.7
550 leptin deficiency or dysfunction 9.7
551 infantile liver failure syndrome 1 9.7
552 body mass index quantitative trait locus 18 9.7
553 leukemia, acute lymphoblastic 3 9.7
554 autoimmune lymphoproliferative syndrome, type v 9.7
555 hyperlipoproteinemia, type iii 9.7
556 joint laxity, short stature, and myopia 9.7
557 helix syndrome 9.7
558 body mass index quantitative trait locus 19 9.7
559 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.7
560 body mass index quantitative trait locus 20 9.7
561 lipoprotein quantitative trait locus 9.7
562 angina pectoris 9.7
563 autoimmune pancreatitis 9.7
564 laryngotracheitis 9.7
565 aspiration pneumonia 9.7
566 erythema multiforme 9.7
567 epidemic typhus 9.7
568 multinodular goiter 9.7
569 taeniasis 9.7
570 paraganglioma 9.7
571 atrioventricular block 9.7
572 large cell neuroendocrine carcinoma 9.7
573 interleukin-7 receptor alpha deficiency 9.7
574 good syndrome 9.7
575 autism spectrum disorder 9.7
576 alexithymia 9.7
577 apraxia 9.7
578 clostridium difficile colitis 9.7
579 ptosis 9.7
580 lymphoproliferative syndrome 9.7
581 thrombosis 9.7
582 chronic myelomonocytic leukemia 9.7
583 non-alcoholic fatty liver disease 9.7
584 urolithiasis 9.7
585 castleman disease 9.7
586 pleomorphic lipoma 9.7
587 dermatomyositis 9.7
588 berylliosis 9.7
589 lactose intolerance 9.7
590 short bowel syndrome 9.7
591 filariasis 9.7
592 amnestic disorder 9.7
593 dissociative disorder 9.7
594 ovarian disease 9.7
595 social phobia 9.7
596 tetanus 9.7
597 megacolon 9.7
598 cardiac tamponade 9.7
599 choledocholithiasis 9.7
600 myopia 9.7
601 nephrotic syndrome 9.7
602 denture stomatitis 9.7
603 dieulafoy lesion 9.7
604 neurogenic bladder 9.7
605 secondary hyperparathyroidism 9.7
606 capillariasis 9.7
607 von willebrand's disease 9.7
608 acute kidney tubular necrosis 9.7
609 hypertrophic pyloric stenosis 9.7
610 leiomyoma 9.7
611 telangiectasis 9.7
612 hypochondriasis 9.7
613 dilated cardiomyopathy 9.7
614 megaesophagus 9.7
615 pneumatosis cystoides intestinalis 9.7
616 typhoid fever 9.7
617 exocrine pancreatic insufficiency 9.7
618 scrub typhus 9.7
619 hepatic encephalopathy 9.7
620 cholestasis 9.7
621 obstructive jaundice 9.7
622 campylobacteriosis 9.7
623 hepatic infarction 9.7
624 clonorchiasis 9.7
625 opisthorchiasis 9.7
626 squamous cell papilloma 9.7
627 somatization disorder 9.7
628 interstitial cystitis 9.7
629 schistosomiasis 9.7
630 selective igg deficiency disease 9.7
631 congenital hypogammaglobulinemia 9.7
632 renal tubular acidosis 9.7
633 sclerosing cholangitis 9.7
634 methylmalonic acidemia 9.7
635 panniculitis 9.7
636 angioedema 9.7
637 thrombocytopenia due to platelet alloimmunization 9.7
638 mental depression 9.7
639 histoplasmosis 9.7
640 cryptosporidiosis 9.7
641 mitral valve stenosis 9.7
642 mononeuritis multiplex 9.7
643 hepatitis c 9.7
644 viral hepatitis 9.7
645 hyperuricemia 9.7
646 rectum cancer 9.7
647 hyperinsulinism 9.7
648 acromegaly 9.7
649 thrombophilia 9.7
650 splenic infarction 9.7
651 hemangioma 9.7
652 agammaglobulinemia 9.7
653 papilloma 9.7
654 myoma 9.7
655 glomerulonephritis 9.7
656 iga glomerulonephritis 9.7
657 mucinous adenocarcinoma 9.7
658 papillary adenocarcinoma 9.7
659 lipid metabolism disorder 9.7
660 mood disorder 9.7
661 appendix adenocarcinoma 9.7
662 skin disease 9.7
663 pleural empyema 9.7
664 pituitary adenoma 9.7
665 lynch syndrome 9.7
666 vulvitis 9.7
667 acute myocarditis 9.7
668 heart valve disease 9.7
669 bile duct disease 9.7
670 biliary dyskinesia 9.7
671 hyperglycemia 9.7
672 myopathy 9.7
673 milk allergy 9.7
674 klatskin's tumor 9.7
675 subependymal giant cell astrocytoma 9.7
676 infertility 9.7
677 human immunodeficiency virus infectious disease 9.7
678 sleep disorder 9.7
679 colonic disease 9.7
680 gastric squamous cell carcinoma 9.7
681 lymphoepithelioma-like carcinoma 9.7
682 fibromyalgia 9.7
683 hypersplenism 9.7
684 plasma cell neoplasm 9.7
685 gastric tubular adenocarcinoma 9.7
686 monoclonal gammopathy of uncertain significance 9.7
687 parathyroid adenoma 9.7
688 chronic kidney disease 9.7
689 barrett's adenocarcinoma 9.7
690 gastric signet ring cell adenocarcinoma 9.7
691 tertiary syphilis 9.7
692 afferent loop syndrome 9.7
693 actinomycosis 9.7
694 bullous pemphigoid 9.7
695 pyoderma gangrenosum 9.7
696 chronic intestinal vascular insufficiency 9.7
697 subacute delirium 9.7
698 myeloid sarcoma 9.7
699 neurofibromatosis 9.7
700 in situ carcinoma 9.7
701 vascular dementia 9.7
702 metagonimiasis 9.7
703 rosacea 9.7
704 sideroblastic anemia 9.7
705 pemphigus 9.7
706 lichen planus 9.7
707 iridocyclitis 9.7
708 acute myocardial infarction 9.7
709 diabetes insipidus 9.7
710 pulmonary embolism 9.7
711 bronchiectasis 9.7
712 esophagus squamous cell papilloma 9.7
713 xanthogranulomatous cholecystitis 9.7
714 median arcuate ligament syndrome 9.7
715 mixed phenotype acute leukemia 9.7
716 hemophilia 9.7
717 myotonic dystrophy 9.7
718 mitochondrial disorders 9.7
719 sickle cell disease 9.7
720 acute graft versus host disease 9.7
721 autoimmune enteropathy 9.7
722 chromosomal triplication 9.7
723 cutis verticis gyrata 9.7
724 cytomegalic inclusion disease 9.7
725 enteropathy-associated t-cell lymphoma 9.7
726 haemophilus influenzae 9.7
727 hemorrhagic proctocolitis 9.7
728 hereditary amyloidosis 9.7
729 homologous wasting disease 9.7
730 immunoglobulin g deficiency 9.7
731 lymphangiectasis 9.7
732 lymphomatous thyroiditis 9.7
733 lymphosarcoma 9.7
734 oral lichen planus 9.7
735 pediatric ulcerative colitis 9.7
736 primary agammaglobulinemia 9.7
737 rosai-dorfman disease 9.7
738 stenotrophomonas maltophilia infection 9.7
739 depression 9.7
740 aneurysm 9.7
741 angiomatosis 9.7
742 back pain 9.7
743 encephalopathy 9.7
744 head injury 9.7
745 paresthesia 9.7
746 pituitary tumors 9.7
747 postherpetic neuralgia 9.7
748 syncope 9.7
749 t-cell non-hodgkin lymphoma 9.7
750 systemic autoimmune disease 9.7
751 rapidly involuting congenital hemangioma 9.7
752 refractory celiac disease 9.7
753 erythema multiforme major 9.7
754 pik3ca-related overgrowth syndrome 9.7
755 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.7
756 severe immune-mediated enteropathy 9.7
757 thrombotic microangiopathy 9.7
758 hereditary stomatocytosis 9.7
759 undetermined colitis 9.7
760 aregenerative anemia 9.7

Graphical network of the top 20 diseases related to Gastritis:



Diseases related to Gastritis

Symptoms & Phenotypes for Gastritis

UMLS symptoms related to Gastritis:


dyspepsia, gastric irritation

Drugs & Therapeutics for Gastritis

PubMed Health treatment related to Gastritis: 62

If you notice that stress , alcohol or nicotine affect your symptoms, you can try to change your diet, stop drinking alcohol, quit smoking and reduce stress in everyday life. If these lifestyle changes are not enough to relieve the symptoms, medication is considered. Gastritis not caused by Helicobacter pylori is usually treated with medication to lower acid levels. Depending on the type and severity of the symptoms, the following drugs can be used: Proton pump inhibitors (PPIs) like omeprazole or pantoprazole reduce the production of stomach acid. H2 blockers such as ranitidine and famotidine also reduce acid production. Antacids like aluminium hydroxide or magnesium hydroxide neutralize the acid already in your stomach . If the gastritis is caused by a Helicobacter infection and is accompanied by noticeable symptoms, it will be treated using a combination of two or three antibiotics and an acid-lowering proton pump inhibitor . If the gastritis is caused by an NSAID painkiller, it is a good idea to consult your doctor about switching to a different painkiller or combining it with an acid-lowering medication. Should an NSAID have to be taken regularly, it is possible to take it along with acid-lowering medication from the start, as a precaution.

Drugs for Gastritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 242, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sucralfate Approved Phase 4 54182-58-0
2
Methylcobalamin Approved, Investigational Phase 4 13422-55-4
3
Hydroxocobalamin Approved Phase 4 13422-51-0 15589840 11953898
4
Amphotericin B Approved, Investigational Phase 4 1397-89-3 5280965 14956
5
Ethanol Approved Phase 4 64-17-5 702
6
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
7
Nitazoxanide Approved, Investigational, Vet_approved Phase 4 55981-09-4 41684
8
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
9
Titanium dioxide Approved Phase 4 13463-67-7
10
Sodium citrate Approved, Investigational Phase 4 68-04-2
11
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
12
Potassium citrate Approved, Investigational, Vet_approved Phase 4 866-84-2
13
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
14
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
15
Ofloxacin Approved Phase 4 82419-36-1 4583
16
Azithromycin Approved Phase 4 83905-01-5 447043 55185
17
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
18
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
19
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
20
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
21
Cyanocobalamin Approved, Nutraceutical Phase 4 68-19-9 44176380
22
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
23
Coenzyme Q10 Approved, Investigational, Nutraceutical Phase 4 303-98-0 5281915
24
Rebamipide Investigational Phase 4 90098-04-7
25
Cobalamin Experimental Phase 4 13408-78-1 6857388
26
Furazolidone Experimental, Vet_approved Phase 4 67-45-8 5323714 3435
27
Sulforaphane Investigational Phase 4 142825-10-3, 4478-93-7 5350
28 Geranylgeranylacetone Phase 4
29 Antioxidants Phase 4
30 Vitamin B 12 Phase 4
31 Liposomal amphotericin B Phase 4
32 Vitamin B12 Phase 4
33 Norgestimate, ethinyl estradiol drug combination Phase 4
34 Acidophilus Phase 4
35 Bifidobacterium Phase 4
36 Citrate Phase 4
37 Anti-Infective Agents, Local Phase 4
38 Respiratory System Agents Phase 4
39 Antiprotozoal Agents Phase 4
40 Antiparasitic Agents Phase 4
41 Cytochrome P-450 CYP3A Inhibitors Phase 4
42 Expectorants Phase 4
43 diuretics Phase 4
44 Antitubercular Agents Phase 4
45 Antimalarials Phase 4
46 Monoamine Oxidase Inhibitors Phase 4
47 Protective Agents Phase 4
48 Sulforafan Phase 4
49 Hormone Antagonists Phase 4
50 Hormones Phase 4
51 Anesthetics Phase 4
52 Anti-Bacterial Agents Phase 4
53 Cytochrome P-450 Enzyme Inhibitors Phase 4
54 Antibiotics, Antitubercular Phase 4
55 Antineoplastic Agents, Hormonal Phase 4
56 glucocorticoids Phase 4
57 Antiemetics Phase 4
58 Opiate Alkaloids Phase 4
59 Antacids Phase 4
60 Anti-Ulcer Agents Phase 4
61 Gastrointestinal Agents Phase 4
62 Vitamins Phase 4
63 Proton Pump Inhibitors Phase 4
64 Trace Elements Phase 4
65 Nutrients Phase 4
66 Micronutrients Phase 4
67 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4
68 Ubiquinone Phase 4
69 Ranitidine bismuth citrate Phase 4
70
Carisoprodol Approved Phase 3 78-44-4 2576
71
Amitriptyline Approved Phase 3 50-48-6 2160
72
Cyclobenzaprine Approved Phase 3 303-53-7 2895
73
Caffeine Approved Phase 3 58-08-2 2519
74
Clavulanate Approved, Vet_approved Phase 3 58001-44-8 5280980
75
Propofol Approved, Investigational, Vet_approved Phase 2, Phase 3 2078-54-8 4943
76
Ondansetron Approved Phase 3 99614-02-5 4595
77
Pantoprazole Approved Phase 3 102625-70-7 4679
78
Selenium Approved, Investigational, Vet_approved Phase 3 7782-49-2
79
Tocopherol Approved, Investigational Phase 3 1406-66-2, 54-28-4 14986
80
Aspirin Approved, Vet_approved Phase 2, Phase 3 50-78-2 2244
81
Prednisolone phosphate Approved, Vet_approved Phase 2, Phase 3 302-25-0
82
Salicylic acid Approved, Investigational, Vet_approved Phase 2, Phase 3 69-72-7 338
83
Methylprednisolone Approved, Vet_approved Phase 2, Phase 3 83-43-2 6741
84
Methylprednisolone hemisuccinate Approved Phase 2, Phase 3 2921-57-5
85
Clotrimazole Approved, Vet_approved Phase 2, Phase 3 23593-75-1 2812
86
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3 22916-47-8 4189
87
Prednisolone Approved, Vet_approved Phase 2, Phase 3 50-24-8 5755